Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

β-Catenin is required for Ron receptor-induced mammary tumorigenesis.

Wagh PK, Gray JK, Zinser GM, Vasiliauskas J, James L, Monga SP, Waltz SE.

Oncogene. 2011 Aug 25;30(34):3694-704. doi: 10.1038/onc.2011.86. Epub 2011 Mar 21.

2.

Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

McClaine RJ, Marshall AM, Wagh PK, Waltz SE.

Neoplasia. 2010 Aug;12(8):650-8.

3.

Past, present and future of targeted therapy in solid tumors.

Palazzo A, Iacovelli R, Cortesi E.

Curr Cancer Drug Targets. 2010 Aug;10(5):433-61. Review.

PMID:
20384576
4.

Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer.

Arpino G, De Angelis C, Giuliano M, Giordano A, Falato C, De Laurentiis M, De Placido S.

Oncology. 2009;77 Suppl 1:23-37. doi: 10.1159/000258493. Epub 2010 Feb 2. Review.

PMID:
20130429
5.

Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.

Ren Y, Wu L, Frost AR, Grizzle W, Cao X, Wan M.

Mol Cancer. 2009 Nov 27;8:111. doi: 10.1186/1476-4598-8-111.

6.

The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells.

Thobe MN, Gurusamy D, Pathrose P, Waltz SE.

Oncogene. 2010 Jan 14;29(2):214-26. doi: 10.1038/onc.2009.331. Epub 2009 Oct 19.

7.

The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis.

Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE.

Dev Biol. 2009 Sep 1;333(1):173-85. doi: 10.1016/j.ydbio.2009.06.028. Epub 2009 Jul 1.

8.

Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production.

Nikolaidis NM, Gray JK, Gurusamy D, Fox W, Stuart WD, Huber N, Waltz SE.

Shock. 2010 Feb;33(2):197-204. doi: 10.1097/SHK.0b013e3181ae8155.

9.

Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Wagh PK, Peace BE, Waltz SE.

Adv Cancer Res. 2008;100:1-33. doi: 10.1016/S0065-230X(08)00001-8. Review.

10.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
11.

Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.

Feng Y, Manka D, Wagner KU, Khan SA.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14718-23. Epub 2007 Sep 4.

12.
14.

Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.

Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE.

Cancer Res. 2006 Dec 15;66(24):11967-74.

15.

The role of estrogen in the initiation of breast cancer.

Russo J, Russo IH.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):89-96. Review.

16.

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells.

Meijer D, van Agthoven T, Bosma PT, Nooter K, Dorssers LC.

Mol Cancer Res. 2006 Jun;4(6):379-86.

17.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.

18.

Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.

Britton DJ, Hutcheson IR, Knowlden JM, Barrow D, Giles M, McClelland RA, Gee JM, Nicholson RI.

Breast Cancer Res Treat. 2006 Mar;96(2):131-46. Epub 2005 Oct 27.

PMID:
16261397
19.

Genes that mediate breast cancer metastasis to lung.

Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagué J.

Nature. 2005 Jul 28;436(7050):518-24.

20.

Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer.

Peace BE, Toney-Earley K, Collins MH, Waltz SE.

Cancer Res. 2005 Feb 15;65(4):1285-93.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk